ES2109478T3 - Polisacaridos sulfatados, procedimiento de preparacion, composiciones farmaceuticas y utilizacion. - Google Patents

Polisacaridos sulfatados, procedimiento de preparacion, composiciones farmaceuticas y utilizacion.

Info

Publication number
ES2109478T3
ES2109478T3 ES93904154T ES93904154T ES2109478T3 ES 2109478 T3 ES2109478 T3 ES 2109478T3 ES 93904154 T ES93904154 T ES 93904154T ES 93904154 T ES93904154 T ES 93904154T ES 2109478 T3 ES2109478 T3 ES 2109478T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
preparation procedure
polysaccharides
sulphate
sulphate polysaccharides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93904154T
Other languages
English (en)
Inventor
Andre Uzan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Application granted granted Critical
Publication of ES2109478T3 publication Critical patent/ES2109478T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0041—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate characterised by the choice of an antithrombatic agent other than heparin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A61L33/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

MEZCLA DE OLIGOSACARIDOS SULFATADOS CONSTITUTIVOS DE HEPARINA. AL MENOS 70% TIENE UNA MASA MOLECULAR ENTRE 5400 Y 7800 DALTONES, Y AL MENOS 5% TIENE UNA MASA MOLECULAR SUPERIOR A 6900 DALTONES.
ES93904154T 1992-02-07 1993-02-04 Polisacaridos sulfatados, procedimiento de preparacion, composiciones farmaceuticas y utilizacion. Expired - Lifetime ES2109478T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9201383A FR2687158B1 (fr) 1992-02-07 1992-02-07 Polysaccharides sulfates, procede de preparation, composition pharmaceutique et utilisation.

Publications (1)

Publication Number Publication Date
ES2109478T3 true ES2109478T3 (es) 1998-01-16

Family

ID=9426428

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93904154T Expired - Lifetime ES2109478T3 (es) 1992-02-07 1993-02-04 Polisacaridos sulfatados, procedimiento de preparacion, composiciones farmaceuticas y utilizacion.

Country Status (17)

Country Link
EP (1) EP0625166B1 (es)
JP (1) JP3218039B2 (es)
KR (1) KR950700334A (es)
AT (1) ATE157991T1 (es)
AU (1) AU671817B2 (es)
CA (1) CA2126241C (es)
DE (1) DE69313826T2 (es)
DK (1) DK0625166T3 (es)
ES (1) ES2109478T3 (es)
FI (1) FI106034B (es)
FR (1) FR2687158B1 (es)
GR (1) GR3024695T3 (es)
HU (1) HU214327B (es)
MX (1) MX9300584A (es)
NO (1) NO307466B1 (es)
NZ (1) NZ249165A (es)
WO (1) WO1993016112A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
EP0735050B1 (en) * 1995-03-31 2002-09-25 Hamilton Civic Hospitals Research Development, Inc. Compositions for inhibiting thrombogenesis
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
US6075013A (en) * 1997-06-06 2000-06-13 Hamilton Civic Hospitals Research Development Inc. Modified low molecular weight heparin that inhibits clot associated coagulation factors
JP4828795B2 (ja) 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
EP2404939A3 (en) 2006-05-25 2012-03-21 Momenta Pharmaceuticals, Inc. Low molecular weight heparin composition and uses thereof
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
CA3020369C (en) * 2010-09-14 2019-11-26 University Of Miyazaki High purity heparin and production method therefor
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945595A1 (de) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach Verfahren zur herstellung von niedermolekularem heparin bzw. seinen salzen
FR2622450B1 (fr) * 1987-11-03 1991-02-22 Sanofi Sa Association heparine/dermatane sulfate
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
FR2663639B1 (fr) * 1990-06-26 1994-03-18 Rhone Poulenc Sante Melanges de polysaccharides de bas poids moleculaires procede de preparation et utilisation.
FR2675806B1 (fr) * 1991-04-23 1994-06-10 Rhone Poulenc Rorer Sa Polysaccharides sulfates, procede de preparation, composition pharmaceutique et utilisation.

Also Published As

Publication number Publication date
NO307466B1 (no) 2000-04-10
FR2687158A1 (fr) 1993-08-13
AU3505193A (en) 1993-09-03
FR2687158B1 (fr) 1995-06-30
DE69313826D1 (de) 1997-10-16
FI106034B (fi) 2000-11-15
DE69313826T2 (de) 1998-02-12
NZ249165A (en) 1996-01-26
CA2126241C (fr) 2004-06-22
HU214327B (hu) 1998-03-02
HUT67878A (en) 1995-05-29
ATE157991T1 (de) 1997-09-15
AU671817B2 (en) 1996-09-12
GR3024695T3 (en) 1997-12-31
MX9300584A (es) 1993-08-01
NO942897D0 (es) 1994-08-04
NO942897L (no) 1994-08-04
HU9401994D0 (en) 1994-09-28
KR950700334A (ko) 1995-01-16
JPH07503496A (ja) 1995-04-13
EP0625166A1 (fr) 1994-11-23
EP0625166B1 (fr) 1997-09-10
WO1993016112A1 (fr) 1993-08-19
DK0625166T3 (da) 1998-02-02
JP3218039B2 (ja) 2001-10-15
CA2126241A1 (fr) 1993-08-19
FI943642A (fi) 1994-08-05
FI943642A0 (fi) 1994-08-05

Similar Documents

Publication Publication Date Title
IL61201A (en) Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
CA2023970A1 (en) Collagen compositions and methods for preparation thereof
AU627615B2 (en) Self-extinguishing polymeric compositions
IT8921066A0 (it) Composizioni polimeriche autoestinguenti.
IL100229A0 (en) N,o-sulphated heparosans,their preparation and pharmaceutical compositions containing them
ES2109478T3 (es) Polisacaridos sulfatados, procedimiento de preparacion, composiciones farmaceuticas y utilizacion.
IL93490A0 (en) Pharmaceutical compositions comprising ranitidine
GB8909022D0 (en) Pharmaceutical compositions
IT1238685B (it) Polisaccaridi ad azione immunomodulatrice da astragalus membranaceous e composizioni farmaceutiche che li contengono
CA2026990A1 (en) Anti-hiv agent
NZ234595A (en) N-aryl arylamide derivatives and pharmaceutical compositions thereof
ZA922874B (en) Sulphated polysaccharides,their preparation,pharmaceutical compositions containing them and their use
EP0409499A3 (en) Pharmaceutical compositions
NZ212915A (en) 9-oxo-15-alpha-hydroxy-16-(substituted) phenoxy-17,18,19,20-tetranorprosta-4,5,13(e)-triene prostaglandins and pharmaceutical compositions
GB8907057D0 (en) Polysaccharide compositions
IL95563A0 (en) Substituted amino-pyridines,their preparation and pharmaceutical compositions containing them
NZ221542A (en) (4,2,0) bicyclooctane derivatives and pharmaceutical compositions
IT9021332A0 (it) Expolimero ottenuto a partire da ceppi selezionati del genere bifidobacterium, suo procedimento di preparazione e composizioni farmaceutiche che lo contengono
PT86665A (pt) Process for the preparation of 14,15-substituted lanosterols and of hypocholesterolemic compositions containing the same
NZ236473A (en) 2,19-methyleneoxy and 2,19-methylenethio bridged steroids and pharmaceutical compositions
IT9022115A0 (it) Nuovi derivati di selenofene, un procedimento per la loro preparazionee composizioni che li contengono
GB8909906D0 (en) Pharmaceutical compositions
IL96273A0 (en) Fibrous compositions and fibrous structures including the same
IT8622051A0 (it) Composizioni farmaceutiche adattivita' cicatrizzante.
IL94084A0 (en) Naphthalenyl-3h-1,2,3,5-oxathiazole 2-oxides,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 625166

Country of ref document: ES